Compare Revvity Inc (RVTY) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Royal Bank of Canada — how do they compare? Revvity Inc trades at $124.14 (market cap $13.82B), while Royal Bank of Canada trades at $206.91 (market cap $286.95B). The key difference: Royal Bank of Canada is far larger — about 20.8× Revvity Inc's market cap, and Royal Bank of Canada pays the higher dividend (2.45%). Which is the better fit depends on your goals.
| RVTY | RY | |
|---|---|---|
Market Cap | $13.82B | $286.95B |
Sector | Technology | Financials |
52-Week High | $130.94 | $217.87 |
52-Week Low | $82.26 | $143.64 |
Enterprise Value | $16.14B | — |
Dividend Yield | 0.23% | 2.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% over 24 hours, with a bullish technical signal driven by moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, supported by diagnostics growth and improved cash flow. Recent news includes the acquisition of Human Cell Design and product launches, indicating strategic expansion.
Outlook remains positive with a consensus price target of $136.20, offering ~7% upside, but high P/E of 59.54 poses valuation risk. Key opportunities include earnings momentum and innovation; risks involve premium valuation and competitive pressures in the healthcare sector.
Royal Bank of Canada (RY) trades at $209.00, down 0.76% on the day, with strong technical momentum showing bullish moving averages and support at $208. The company delivered three consecutive earnings beats, with Q2 2026 EPS of $3.07 exceeding expectations, while revenue grew to $66.53 billion in 2025 with a robust 32.01% net income margin. Recent news highlights record quarterly earnings and dividend declarations.
RY presents a compelling investment case with consistent earnings outperformance and strong profitability metrics, though stretched valuations and mixed analyst sentiment warrant caution. The stock's technical strength and fundamental growth support upside potential, but investors should monitor debt levels and competitive pressures in the banking sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
